Education
About Us
Working with TipRanks
Follow Us
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
Ttx-Mc138
Advanced Solid Tumor
Phase I/II
Active Not Recruiting
Study of TTX-MC138 in Subjects With Advanced Solid Tumors
Dec 12, 2023
―
Ttx-Mc138-Nodaga-Cu64
Advanced Solid Tumor
Early Phase I
Completed
A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors
May 26, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does TransCode Therapeutics (RNAZ) have in its pipeline
RNAZ is currently developing the following drugs: Ttx-Mc138, Ttx-Mc138-Nodaga-Cu64. These drug candidates are in various stages of clinical development as the company works toward FDA approval.